Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.04 USD | -1.94% | -66.21% | -49.94% |
May. 24 | Top Midday Decliners | MT |
May. 24 | Sector Update: Health Care Stocks Advance Pre-Bell Friday | MT |
Financials (USD)
Sales 2024 * | 200K | Sales 2025 * | 27.49M | Capitalization | 104M |
---|---|---|---|---|---|
Net income 2024 * | -118M | Net income 2025 * | -109M | EV / Sales 2024 * | 521 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.79 x |
P/E ratio 2024 * |
-1.05
x | P/E ratio 2025 * |
-1.46
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.43% |
Latest transcript on Verastem, Inc.
1 week | -65.41% | ||
Current month | -58.20% | ||
1 month | -56.69% | ||
3 months | -67.44% | ||
6 months | -34.00% | ||
Current year | -48.76% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 63 | 10-12-31 |
Daniel Calkins
DFI | Director of Finance/CFO | 37 | 18-11-30 |
Jonathan Pachter
CTO | Chief Tech/Sci/R&D Officer | 66 | 11-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 67 | 17-05-02 |
John Johnson
BRD | Director/Board Member | 66 | 20-04-22 |
Michael Kauffman
CHM | Chairman | 60 | 12-11-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 4.072 | -1.17% | 3 109 656 |
24-05-24 | 4.12 | -66.17% | 19,714,895 |
24-05-23 | 12.18 | +2.53% | 308,763 |
24-05-22 | 11.88 | -1.49% | 74,941 |
24-05-21 | 12.06 | +3.88% | 393,060 |
Delayed Quote Nasdaq, May 28, 2024 at 01:02 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.76% | 104M | |
+9.83% | 118B | |
+9.94% | 106B | |
-11.98% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.80% | 15.97B | |
+6.55% | 14.03B | |
+16.49% | 11.67B |
- Stock Market
- Equities
- VSTM Stock